Literature DB >> 35041015

An observational study of antipsychotic medication discontinuation in first-episode psychosis: clinical and functional outcomes.

Ashok Malla1, Srividya N Iyer2,3, Ridha Joober2,3, Thara Rangaswamy4, Padmavati Ramachandran4, Norbert Schmitz2, Aarati Taksal3, Greeshma Mohan4, Howard C Margolese2,5.   

Abstract

PURPOSE: To study the impact of supervised antipsychotic medication discontinuation on clinical and functional outcomes in first-episode psychosis (FEP) in two different cultural environments.
METHOD: FEP patients(N = 253), treated in two early intervention services (Montreal, Canada and Chennai, India) for 2 years, were assessed for medication use, positive and negative symptom remission and social-occupational functioning at regular intervals.
RESULTS: Between months 4 and 24 of treatment, 107 patients discontinued medication ('Off'group) as compared to 146 who stayed on medication ('On'group). Medication discontinuation was higher in Chennai as compared to Montreal (n = 80, 49.07% vs n = 27, 16.87%; χ2 37.80, p < 0.001), with no difference in time to discontinuation [Means(SDs) = 10.64(6.82) and 10.04(5.43), respectively, p = 0.71). At month 24 (N = 235), there were no differences in the rate of positive symptom remission between the on and Off groups (81.5 vs 88.0%, respectively) at both sites. The rate of negative symptom remission was lower among patients in the On compared to the Off group (63.2 vs 87.9%, respectively, χ2 = 17.91, p < 0.001), but only in Montreal (55.4% vs 80.0%, respectively, χ2 = 4.12, p < 0.05). Social and Occupational Functioning Assessment Scale scores were equally high in both Off and On medication groups in Chennai [Means (SDs) = 79.43(12.95) and 73.59(17.63), respectively] but higher in the Off compared to the On group in Montreal Means (SDs) = 77.47(14.97) and 64.94(19.02), respectively; Time × site interaction F = 3.96(1,217), p < 0.05]. Medication status (On-Off) had no impact on the outcomes, independent of other variables known to influence outcomes.
CONCLUSION: Certain cultural environments and patient characteristics may facilitate supervised discontinuation of antipsychotic medication following treatment of an FEP without negative consequences.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Adherence; Canada; Early intervention in psychosis; FEP; India; Medication discontinuation; Remission

Mesh:

Substances:

Year:  2022        PMID: 35041015     DOI: 10.1007/s00127-022-02230-0

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  35 in total

1.  Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study.

Authors:  Ashok Malla; Ross Norman; Norbert Schmitz; Rahul Manchanda; Laura Béchard-Evans; Jatinder Takhar; Raj Haricharan
Journal:  Psychol Med       Date:  2006-03-06       Impact factor: 7.723

Review 2.  Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment.

Authors:  Jennifer P Wisdom; Jennifer I Manuel; Robert E Drake
Journal:  Psychiatr Serv       Date:  2011-09       Impact factor: 3.084

3.  Is going into stable symptomatic remission associated with a more positive development of life satisfaction? A 10-year follow-up study of first episode psychosis.

Authors:  Erlend Strand Gardsjord; Kristin Lie Romm; Jan Ivar Røssberg; Svein Friis; Helene Eidsmo Barder; Julie Evensen; Ulrik Haahr; Wenche Ten Velden Hegelstad; Inge Joa; Jan Olav Johannessen; Johannes Langeveld; Tor Ketil Larsen; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Per Vaglum; Thomas McGlashan; Ingrid Melle
Journal:  Schizophr Res       Date:  2017-07-09       Impact factor: 4.939

Review 4.  Predictors of functional recovery in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies.

Authors:  Olga Santesteban-Echarri; Mercedes Paino; Simon Rice; César González-Blanch; Patrick McGorry; John Gleeson; Mario Alvarez-Jimenez
Journal:  Clin Psychol Rev       Date:  2017-10-06

Review 5.  Family intervention for schizophrenia.

Authors:  Fiona Pharoah; Jair Mari; John Rathbone; Winson Wong
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

6.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Authors:  D Robinson; M G Woerner; J M Alvir; R Bilder; R Goldman; S Geisler; A Koreen; B Sheitman; M Chakos; D Mayerhoff; J A Lieberman
Journal:  Arch Gen Psychiatry       Date:  1999-03

Review 7.  Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies.

Authors:  M Alvarez-Jimenez; A Priede; S E Hetrick; S Bendall; E Killackey; A G Parker; P D McGorry; J F Gleeson
Journal:  Schizophr Res       Date:  2012-06-01       Impact factor: 4.939

8.  Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials.

Authors:  Miguel Camacho-Gomez; Pere Castellvi
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

Review 9.  New generation antipsychotics for first episode schizophrenia.

Authors:  C Rummel; J Hamann; W Kissling; S Leucht
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 10.  Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.

Authors:  Craig Karson; Ruth A Duffy; Anna Eramo; Anna-Greta Nylander; Steve J Offord
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.